Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Current Topics in Medicinal Chemistry
|
November 15, 2008
Neither typical nor atypical: LY404039 provides proof of concept that selective targeting of mGluR2/3 receptors is a valid mechanism for obtaining antipsychotic efficacy
Evan P Lebois
Current Topics in Medicinal Chemistry
|
January 26, 2011
The evolution of histamine H₃ antagonists/inverse agonists
Evan P Lebois, Carrie K Jones, Craig W Lindsley
Current Opinion in Chemical Biology
|
March 18, 2008
Allosteric modulation of kinases and GPCRs: design principles and structural diversity
Jana A Lewis, Evan P Lebois, Craig W Lindsley
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Evan P Lebois, Chinnappa D Kodira, Robert D Hubbard, et al.
Neuroscience and Biobehavioral Reviews
|
January 21, 2019
The reverse translation of a quantitative neuropsychiatric framework into preclinical studies: Focus on social interaction and behavior
Tatiana Peleh, Kevin G O Ike, Emma J Wams, et al.
ACS Chemical Neuroscience
|
August 2, 2016
Effects of Selective M<sub>1</sub> Muscarinic Receptor Activation on Hippocampal Spatial Representations and Neuronal Oscillations
Evan P Lebois, John B Trimper, Chun Hu, et al.
Pharmacology
|
February 1, 2014
Effects of selective activation of M1 and M4 muscarinic receptors on object recognition memory performance in rats
Claire R Galloway, Evan P Lebois, Shezza L Shagarabi, et al.
Hippocampus
|
May 10, 2018
Hippocampal place cell dysfunction and the effects of muscarinic M<sub>1</sub> receptor agonism in a rat model of Alzheimer's disease
Claire R Galloway, Kaushik Ravipati, Suyashi Singh, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 17, 2008
Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators
Colleen M Niswender, Evan P Lebois, Qingwei Luo, et al.
Drug News & Perspectives
|
June 4, 2010
The antipsychotic potential of muscarinic allosteric modulation
Thomas M Bridges, Evan P LeBois, Corey R Hopkins, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Current Topics in Medicinal Chemistry
|
November 15, 2008
Neither typical nor atypical: LY404039 provides proof of concept that selective targeting of mGluR2/3 receptors is a valid mechanism for obtaining antipsychotic efficacy
Evan P Lebois
Current Topics in Medicinal Chemistry
|
January 26, 2011
The evolution of histamine H₃ antagonists/inverse agonists
Evan P Lebois, Carrie K Jones, Craig W Lindsley
Current Opinion in Chemical Biology
|
March 18, 2008
Allosteric modulation of kinases and GPCRs: design principles and structural diversity
Jana A Lewis, Evan P Lebois, Craig W Lindsley
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Evan P Lebois, Chinnappa D Kodira, Robert D Hubbard, et al.
Neuroscience and Biobehavioral Reviews
|
January 21, 2019
The reverse translation of a quantitative neuropsychiatric framework into preclinical studies: Focus on social interaction and behavior
Tatiana Peleh, Kevin G O Ike, Emma J Wams, et al.
ACS Chemical Neuroscience
|
August 2, 2016
Effects of Selective M<sub>1</sub> Muscarinic Receptor Activation on Hippocampal Spatial Representations and Neuronal Oscillations
Evan P Lebois, John B Trimper, Chun Hu, et al.
Pharmacology
|
February 1, 2014
Effects of selective activation of M1 and M4 muscarinic receptors on object recognition memory performance in rats
Claire R Galloway, Evan P Lebois, Shezza L Shagarabi, et al.
Hippocampus
|
May 10, 2018
Hippocampal place cell dysfunction and the effects of muscarinic M<sub>1</sub> receptor agonism in a rat model of Alzheimer's disease
Claire R Galloway, Kaushik Ravipati, Suyashi Singh, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 17, 2008
Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators
Colleen M Niswender, Evan P Lebois, Qingwei Luo, et al.
Drug News & Perspectives
|
June 4, 2010
The antipsychotic potential of muscarinic allosteric modulation
Thomas M Bridges, Evan P LeBois, Corey R Hopkins, et al.
Page
of 2